These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5960304)

  • 1. 2,4-diamino-6-substituted-5-(4-carbethoxyphenylazo) pyrimidines as irreversible inhibitors of folic acid reductase.
    Hampshire J; Hebborn P; Triggle AM; Triggle DJ
    J Pharm Sci; 1966 Apr; 55(4):453-4. PubMed ID: 5960304
    [No Abstract]   [Full Text] [Related]  

  • 2. ON THE MECHANISM OF FOLIC ACID REDUCTASE INHIBITION.
    COLLIN R; PULLMAN B
    Biochim Biophys Acta; 1964 Aug; 89():232-41. PubMed ID: 14203171
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible enzyme inhibitors. CLXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 2,4-diamino-5(3,4-dichlorophenyl)pyrimidine with 6 substituents and some factors in their cell wall transport.
    Baker BR; Vermeulen NM
    J Med Chem; 1970 Jan; 13(1):82-6. PubMed ID: 5460895
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):89-91. PubMed ID: 5763048
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential folic acid antagonists. 3. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines.
    Hampshire J; Hebborn P; Triggle AM; Triggle DJ
    J Med Chem; 1968 May; 11(3):583-8. PubMed ID: 5656500
    [No Abstract]   [Full Text] [Related]  

  • 6. Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Jan; 12(1):108-11. PubMed ID: 5763004
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):86-8. PubMed ID: 5763047
    [No Abstract]   [Full Text] [Related]  

  • 8. ANALOGS OF TETRAHYDROFOLIC ACID. 18. ON THE MODE OF BINDING OF SOME 6-ARYL- AND 6-ARALKYLPYRIMIDINES TO FOLIC REDUCTASE.
    BAKER BR; SHAPIRO HS; WERKHEISER WC
    J Med Chem; 1965 May; 8():283-7. PubMed ID: 14323133
    [No Abstract]   [Full Text] [Related]  

  • 9. Irreversible enzyme inhibitors. CXXXV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(p-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):79-81. PubMed ID: 5763045
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. CXXXIV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):74-8. PubMed ID: 5763044
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential folic acid antagonists. 6. Potential irreversible folate reductase inhibitors derived from 2,4-diamino-5-arylazopyrimidines.
    Chatterjee SS; Moran JF; Triggle DJ; Wayne A
    J Med Chem; 1971 Dec; 14(12):1244-5. PubMed ID: 5116249
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. CXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines. 3.
    Baker BR; Huang PC; Meyer RB
    J Med Chem; 1968 May; 11(3):475-82. PubMed ID: 5241405
    [No Abstract]   [Full Text] [Related]  

  • 13. ANALOGS OF TETRAHYDROFOLIC ACID. XVII. ON THE MODE OF BINDING OF THE P-AMINOBENZOYL MOIETY OF N-(2-AMINO-4-HYDROXY-6-METHYL-5-PYRIMIDYLPROPYL)-P-AMINOBENZOYL-L-GLUTAMIC ACID TO DIHYDROFOLIC REDUCTASE.
    BAKER BR; JORDAAN JH
    J Med Chem; 1965 Jan; 8():35-41. PubMed ID: 14287264
    [No Abstract]   [Full Text] [Related]  

  • 14. Irreversible enzyme inhibitors. CXX. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines with tissue specificity.
    Baker BR; Huang PC
    J Med Chem; 1968 May; 11(3):495-500. PubMed ID: 5241409
    [No Abstract]   [Full Text] [Related]  

  • 15. Analogs of tetrahydrofolic acid XXV. 2,4-Diamino-6-phenethylpteridine, an inhibitor of dihydrofolic reductase.
    Baker BR; Ho BT
    J Pharm Sci; 1965 Sep; 54(9):1261-5. PubMed ID: 5881216
    [No Abstract]   [Full Text] [Related]  

  • 16. 6-substituted 2,4-diamino-5-(4-carbethoxyphenylazo)pyrimidines as potential precursors of tetrahydropteridine antimetabolites.
    Chadwick M; Hampshire J; Hebborn P; Triggle AM; Triggle DJ
    J Med Chem; 1966 Nov; 9(6):874-6. PubMed ID: 6013234
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR; Vermeulen NM; Ashton WT; Ryan AJ
    J Med Chem; 1970 Nov; 13(6):1130-40. PubMed ID: 5479852
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.
    Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):818-22. PubMed ID: 7277386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METHYLATED PURINES AND PYRIMIDINES. II. SYNTHESIS AND PROPERTIES OF 2,6-DIAMINO-5-(METHYLAMINO)-4-PYRIMIDINOL.
    SPRECHER M; SPRINSON DB
    Biochemistry; 1965 Apr; 4():655-61. PubMed ID: 14323567
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines.
    Hampshire J; Hebborn P; Triggle AM; Triggle DJ; Vickers S
    J Med Chem; 1965 Nov; 8(6):745-9. PubMed ID: 5885064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.